Comind Technologies Ltd. secured $60 million in funding for its optical neuromonitoring device which non-invasively measures ...

In vaccine development, one might think that targeting multiple epitopes increases the likelihood of improving outcomes.

The 2025 Annual Congress of the European Society for Medical Oncology (ESMO) featured a track on tumor-agnostic therapies – the first time such a track has been included at ESMO, or at any major ...

The U.K. Competition and Markets Authority (CMA) has issued draft guidelines for remedies for mergers and acquisitions, which ...

Chugai Pharmaceutical Co. Ltd. and Rani Therapeutics LLC have entered into a collaboration and global license agreement to develop and commercialize an oral product that encompasses Rani’s oral ...

While positive results from the investigator-led phase II CHOPIN trial at the 2025 European Society of Medical Oncology (ESMO ...

The U.S. FDA approved 17 drugs in September 2025, following 18 approvals in August and 17 in July. That brings the ...

Grail LLC has presented data showing that when added to standard screening procedures for breast, cervical, colorectal and ...

Dianthus Therapeutics Inc. has joined the recent trend of companies licensing therapies in development from China. The ...

Researchers from Cincinnati Children’s Hospital Medical Center and collaborating institutions in the U.S. have developed a ...

The U.K. Medicines and Healthcare Products Regulatory Agency reported the winners of the second phase of the AI Airlock challenge, which includes the Tortus AI, a medical scribe system developed by ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: A.D.A.M. Innovations, Celltrion, Genedx, Rhythio Medical, Sophia Genetics, Wellscare.